Status:
COMPLETED
PREdictive Value of COntrast voluMe to creatinINe Clearance Ratio
Lead Sponsor:
Guangdong Provincial People's Hospital
Conditions:
Contrast Induced Nephropathy
Eligibility:
All Genders
18+ years
Brief Summary
To determine a relatively safe contrast media volume to creatinine clearance cut-off value to avoid contrast-induced nephropathy in patients following coronary angiography
Detailed Description
Contrast media volume to creatinine clearance (V/CrCl) ratios were obtained from consecutive consenting patients after coronary angiography. Receiver-operator characteristic (ROC) curves were used to ...
Eligibility Criteria
Inclusion
- patients who agreed to stay in the hospital for 2-3 days after coronary angiography
- provided written informed consent
Exclusion
- pregnancy
- lactation
- intravascular administration of an contrast medium within the previous seven days
- treatment with metformin,aminoglycosides,N-acetylcysteine (NAC),nonsteroidal anti-inflammatory drugs within the previous 48 h
- intake of nephrotoxic drugs within the previous seven days
- history of serious reactions to contrast mediums， severe concomitant disease renal transplantation , or end-stage renal disease necessitating dialysis
- patients who died during coronary angiography
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT01400295
Start Date
December 1 2010
End Date
September 1 2013
Last Update
September 16 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong Cardiovascular Institute,Guangdong General Hospital
Guangzhou, Guangdong, China, 510080